• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铀体内清除动力学-退役核燃料工人的长期随访研究。

Uranium Body Clearance Kinetics-A Long-term Follow-up Study of Retired Nuclear Fuel Workers.

机构信息

Department of Medical Radiation Physics, and Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.

Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.

出版信息

Health Phys. 2024 Oct 1;127(4):520-535. doi: 10.1097/HP.0000000000001861. Epub 2024 Jul 24.

DOI:10.1097/HP.0000000000001861
PMID:39058313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11460735/
Abstract

Nuclear industry workers exposed to uranium aerosols may risk kidney damage and radiation-induced cancer. This warrants the need for well-established dose and risk assessments, which can be greatly improved by using material-specific absorption parameters in the ICRP Human Respiratory Tract Model. The present study focuses on the evaluation of the slow dissolution rate ( s s , d -1 ), a parameter that is difficult to quantify with in vitro dissolution studies, especially for more insoluble uranium compounds. A long-term follow-up of urinary excretion after the cessation of chronic inhalation exposure can provide a better estimate of the slow-rate dissolution. In this study, two workers, previously working for >20 y at a nuclear fuel fabrication plant, provided urine samples regularly for up to 6 y. One individual had worked at the pelletizing workshop with the known presence of uranium dioxide (UO 2 ) and triuranium octoxide (U 3 O 8 ). The second individual worked at the conversion workshop where multiple compounds, including uranium hexafluoride (UF 6 ), uranium dioxide (UO 2 ), ammonium uranyl carbonate, and AUC [UO 2 CO 3 ·2(NH 4 ) 2 CO 3 ], are present. Data on uranium concentration in urine during working years were also available for both workers. The daily excretion of uranium by urine was characterized by applying non-linear least square regression fitting to the urinary data. Material-specific parameters, such as the activity median aerodynamic diameter (AMAD), the respiratory tract absorption parameters, rapid fraction ( f r ,), rapid dissolution rate ( s r , d -1 ), and slow dissolution rate ( s s , d -1 ) and alimentary tract transfer factor ( f A ) acquired from previous work along with default absorption types, were applied to urine data, and the goodness of fit was evaluated. Thereafter intake estimates and dose calculations were performed. For the ex-pelletizing worker, a one-compartment model with a clearance half-time of 662 ± 100 d ( s s = 0.0010 d -1 ) best represented the urinary data. For the ex-conversion worker, a two-compartment model with a major [93% of the initial urinary excretion (A 0 )] fast compartment with a clearance half-time of 1.3 ± 0.4 d ( s r = 0.5 d -1 ) and a minor (7% of A 0 ) slow compartment with a half-time of 394 ± 241 d ( s s = 0.002 d -1 ) provided the best fit. The results from the data-fitting of urinary data to biokinetic models for the ex-conversion worker demonstrated that in vitro derived experimental parameters (AMAD = 20 μm, f r = 0.32, s r = 27 d -1 , s s = 0.0008 d -1 , f A = 0.005) from our previous work best represented the urinary data. This resulted in an estimated intake rate of 0.66 Bq d -1 . The results from the data-fitting of urinary data to biokinetic models for the ex-pelletizing worker indicated that the experimental parameters (AMAD = 10 μm and 20 μm, f r = 0.008, s r = 12 d -1 , f A = 0.00019) from our previous dissolution studies with the slow rate parameter step-wise optimized to urine-data ( s s = 0.0008 d -1 ) gave the best fit. This resulted in an estimated intake rate of 5 Bq d -1 . Experimental parameters derived from in vitro dissolution studies provided the best fit for the subject retired from work at the conversion workshop, where inhalation exposure to a mix of soluble (e.g., AUC, UF 6 ) and relatively insoluble aerosol (e.g., UO 2 ) can be assumed. For the subject retired from work at the pelletizing workshop, which involved exposure to relatively insoluble aerosols (UO 2 and U 3 O 8 ), a considerably higher s s than obtained in dissolution studies provided a better representation of the urinary data and was comparable to reported s s values for UO 2 and U 3 O 8 in other studies. This implies that in vitro dissolution studies of insoluble material can be uncertain. When evaluating the results from the retrospective fitting of urine data, it is evident that the urine samples acquired after cessation of exposure provide less fluctuation. Long-term follow-up of uranium excretion after cessation of exposure is a good alternative for determining absorption parameters and can be considered the most viable way for determining the slow rate for more insoluble material.

摘要

核工业工人接触铀气溶胶可能有肾脏损伤和辐射诱导癌症的风险。这就需要建立完善的剂量和风险评估体系,而使用 ICRP 人类呼吸道模型中的特定物质吸收参数可以大大提高评估效果。本研究重点评估了缓慢溶解率( s s, d -1 ),这是一个很难通过体外溶解研究来定量的参数,特别是对于更难溶解的铀化合物。长期追踪慢性吸入暴露停止后尿液排泄情况,可以更好地估计缓慢溶解率。在这项研究中,两名在核燃料制造厂工作了超过 20 年的工人定期提供尿液样本,最长可达 6 年。其中一名在球团车间工作,已知存在二氧化铀(UO 2 )和三氧化铀八(U 3 O 8 )。第二个人在转化车间工作,那里存在多种化合物,包括六氟化铀(UF 6 )、二氧化铀(UO 2 )、碳酸铀酰铵和 AUC[UO 2 CO 3 ·2(NH 4 ) 2 CO 3 ]。对于这两名工人,我们也有他们在工作期间尿液中铀浓度的数据。通过对尿液数据进行非线性最小二乘回归拟合,描述了铀在尿液中的每日排泄情况。应用以前工作中获得的特定物质参数,如活性中值空气动力学直径(AMAD)、呼吸道吸收参数、快速分数( f r,)、快速溶解率( s r, d -1 )、缓慢溶解率( s s, d -1 )和肠转移系数( f A )以及默认吸收类型,对尿液数据进行拟合,并评估拟合优度。然后进行摄入量估计和剂量计算。对于前球团工人,半衰期为 662±100d( s s = 0.0010 d -1 )的单室模型能更好地代表尿液数据。对于前转化工人,半衰期为 1.3±0.4d( s r = 0.5 d -1 )的主要(93%的初始尿液排泄量[A 0 ])快速隔室和半衰期为 394±241d( s s = 0.002 d -1 )的次要(7%A 0 )缓慢隔室的两室模型提供了最佳拟合。从转化工人尿液数据到生物动力学模型的数据拟合结果表明,从我们之前的工作中获得的体外衍生的实验参数(AMAD=20μm, f r = 0.32, s r = 27 d -1 , s s = 0.0008 d -1 , f A = 0.005)能最好地代表尿液数据。这导致估计的摄入量为 0.66Bq d -1 。从球团工人尿液数据到生物动力学模型的数据拟合结果表明,实验参数(AMAD=10μm和 20μm, f r = 0.008, s r = 12 d -1 , f A = 0.00019)和逐步优化到尿液数据的缓慢溶解率参数( s s = 0.0008 d -1 )提供了最佳拟合。这导致估计的摄入量为 5Bq d -1 。从体外溶解研究中获得的实验参数为从转化车间退休的工人提供了最佳拟合,在那里可以假设吸入暴露于可溶性(例如 AUC、UF 6 )和相对不溶性气溶胶(例如 UO 2 )的混合物。对于从球团车间退休的工人,涉及到相对不溶性气溶胶(UO 2 和 U 3 O 8 )的暴露,从溶解研究中获得的较高的 s s 值能更好地代表尿液数据,与其他研究中报道的 UO 2 和 U 3 O 8 的 s s 值相当。这意味着对不溶性物质的体外溶解研究可能不确定。在评估尿液数据回顾拟合的结果时,显然暴露停止后获得的尿液样本波动较小。停止暴露后长期追踪铀排泄情况是确定吸收参数的好方法,也可以被认为是确定更不溶性物质的缓慢溶解率的最可行方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebff/11460735/950c08002319/hpj-127-520-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebff/11460735/311ab29d58e0/hpj-127-520-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebff/11460735/950c08002319/hpj-127-520-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebff/11460735/311ab29d58e0/hpj-127-520-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebff/11460735/950c08002319/hpj-127-520-g002.jpg

相似文献

1
Uranium Body Clearance Kinetics-A Long-term Follow-up Study of Retired Nuclear Fuel Workers.铀体内清除动力学-退役核燃料工人的长期随访研究。
Health Phys. 2024 Oct 1;127(4):520-535. doi: 10.1097/HP.0000000000001861. Epub 2024 Jul 24.
2
Particle Size Dependent Dissolution of Uranium Aerosols in Simulated Gastrointestinal Fluids.粒径对模拟胃肠道液中铀气溶胶溶解的影响。
Health Phys. 2023 Apr 1;124(4):285-300. doi: 10.1097/HP.0000000000001668. Epub 2023 Jan 20.
3
Particle Size-dependent Dissolution of Uranium Aerosols in Simulated Lung Fluid: A Case Study in a Nuclear Fuel Fabrication Plant.粒径依赖性铀气溶胶在模拟肺液中的溶解:核燃料制造厂的案例研究。
Health Phys. 2022 Jul 1;123(1):11-27. doi: 10.1097/HP.0000000000001564. Epub 2022 May 6.
4
Uranium Aerosol Activity Size Distributions at a Nuclear Fuel Fabrication Plant.铀气溶胶在核燃料制造厂的活性尺寸分布。
Health Phys. 2020 Sep;119(3):327-341. doi: 10.1097/HP.0000000000001254.
5
US Transuranium and Uranium Registries case study on accidental exposure to uranium hexafluoride.美国超铀元素与铀注册中心关于六氟化铀意外暴露的案例研究。
J Radiol Prot. 2015 Mar;35(1):129-51. doi: 10.1088/0952-4746/35/1/129. Epub 2015 Jan 12.
6
Inhalation of U aerosols from UO2 fuel element fabrication.吸入来自二氧化铀燃料元件制造过程中的铀气溶胶。
Health Phys. 1985 Jan;48(1):29-48. doi: 10.1097/00004032-198501000-00003.
7
Determination of the physical and chemical properties, biokinetics, and dose coefficients of uranium compounds handled during nuclear fuel fabrication in France.
Health Phys. 2002 Mar;82(3):279-89. doi: 10.1097/00004032-200203000-00001.
8
Characterisation and dissolution of depleted uranium aerosols produced during impacts of kinetic energy penetrators against a tank.
Radiat Prot Dosimetry. 2003;105(1-4):163-6. doi: 10.1093/oxfordjournals.rpd.a006214.
9
Maximum likelihood analysis of bioassay data from long-term follow-up of two refractory PuO2 inhalation cases.从两个难治性 PuO2 吸入病例的长期随访中生物测定数据的最大似然分析。
Health Phys. 2012 Jul;103(1):70-9. doi: 10.1097/HP.0b013e31824ac627.
10
NTP Toxicity Study Report on the atmospheric characterization, particle size, chemical composition, and workplace exposure assessment of cellulose insulation (CELLULOSEINS).美国国家毒理学计划关于纤维素绝缘材料(CELLULOSEINS)的大气特征、粒径、化学成分及工作场所暴露评估的毒性研究报告
Toxic Rep Ser. 2006 Aug(74):1-62, A1-C2.

本文引用的文献

1
Particle Size Dependent Dissolution of Uranium Aerosols in Simulated Gastrointestinal Fluids.粒径对模拟胃肠道液中铀气溶胶溶解的影响。
Health Phys. 2023 Apr 1;124(4):285-300. doi: 10.1097/HP.0000000000001668. Epub 2023 Jan 20.
2
Particle Size-dependent Dissolution of Uranium Aerosols in Simulated Lung Fluid: A Case Study in a Nuclear Fuel Fabrication Plant.粒径依赖性铀气溶胶在模拟肺液中的溶解:核燃料制造厂的案例研究。
Health Phys. 2022 Jul 1;123(1):11-27. doi: 10.1097/HP.0000000000001564. Epub 2022 May 6.
3
Bioassays in workers exposed to long time random intakes.
工人长期随机摄入的生物测定。
Appl Radiat Isot. 2022 Feb;180:110057. doi: 10.1016/j.apradiso.2021.110057. Epub 2021 Dec 4.
4
ICRP Publication 150: Cancer Risks from Plutonium and Uranium Exposure.国际放射防护委员会第150号出版物:钚和铀暴露所致的癌症风险。
Ann ICRP. 2021 Dec;50(4):1-143. doi: 10.1177/01466453211028020.
5
Uranium Aerosol Activity Size Distributions at a Nuclear Fuel Fabrication Plant.铀气溶胶在核燃料制造厂的活性尺寸分布。
Health Phys. 2020 Sep;119(3):327-341. doi: 10.1097/HP.0000000000001254.
6
ICRP Publication 137: Occupational Intakes of Radionuclides: Part 3.国际放射防护委员会第137号出版物:放射性核素的职业摄入量:第3部分。
Ann ICRP. 2017 Dec;46(3-4):1-486. doi: 10.1177/0146645317734963.
7
EURADOS-IDEAS GUIDELINES (VERSION 2) FOR THE ESTIMATION OF COMMITTED DOSES FROM INCORPORATION MONITORING DATA.EURADOS-IDEAS关于从摄入监测数据估算待积剂量的指南(第2版)
Radiat Prot Dosimetry. 2016 Sep;170(1-4):17-20. doi: 10.1093/rpd/ncv457. Epub 2015 Nov 4.
8
ICRP Publication 130: Occupational Intakes of Radionuclides: Part 1.国际放射防护委员会第130号出版物:放射性核素的职业性摄入量:第1部分。
Ann ICRP. 2015 Sep;44(2):5-188. doi: 10.1177/0146645315577539.
9
US Transuranium and Uranium Registries case study on accidental exposure to uranium hexafluoride.美国超铀元素与铀注册中心关于六氟化铀意外暴露的案例研究。
J Radiol Prot. 2015 Mar;35(1):129-51. doi: 10.1088/0952-4746/35/1/129. Epub 2015 Jan 12.
10
Physico-chemical characteristics of uranium compounds: a review.铀化合物的物理化学特性:综述。
Int J Radiat Biol. 2014 Nov;90(11):975-88. doi: 10.3109/09553002.2014.886796. Epub 2014 May 12.